No evidence of a synergistic effect of HIV infection and diabetes mellitus type 2 on fat distribution, plasma adiponectin or inflammatory markers

被引：0
|
作者：
Malene Hove-Skovsgaard
Julie Abildgaard
Marco Gelpi
Julie Christine Gaardbo
Lilian Kolte
Henrik Ullum
Marius Trøseid
Birgitte Lindegaard
Susanne Dam Nielsen
机构：
[1] Copenhagen University Hospital,Department of Infectious Diseases, Rigshospitalet
[2] University of Copenhagen,The Centre of Inflammation and Metabolism and the Centre for Physical Activity Research, Rigshospitalet
[3] University of Copenhagen,Department of Infectious Diseases, Hvidovre Hospital
[4] University of Copenhagen,Department of Pulmonary
[5] Copenhagen University Hospital, and Infectious Diseases, Nordsjællands Hospital
[6] Oslo University Hospital,Department of Clinical Immunology, Rigshospitalet
[7] Oslo University Hospital,Section of Clinical Immunology and Infectious Diseases
[8] Institute for Clinical Medicine,Research Institute of Internal Medicine
[9] University of Oslo,undefined
来源：
BMC Infectious Diseases | / 20卷
关键词：
HIV infection; Diabetes mellitus type 2; Fat distribution; Adiponectin; IL-6; sCD14;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Effect of valsartan on monocyte/endothelial cell activation markers and adiponectin in hypertensive patients with type 2 diabetes mellitus
    Nomura, S
    Shouzu, A
    Omoto, S
    Nishikawa, M
    Fukuhara, S
    Iwasaka, T
    THROMBOSIS RESEARCH, 2006, 117 (04) : 385 - 392
  • [22] THE EFFECT OF RENAL DENERVATION ON INFLAMMATORY MARKERS IN PATIENTS WITH RESISTANT HYPERTENSION AND DIABETES MELLITUS TYPE 2
    Falkovskaya, A.
    Mordovin, V.
    Pekarskiy, S.
    Baev, A.
    Semke, G.
    Ripp, T.
    Zyubanova, I.
    Kravtchenko, E.
    JOURNAL OF HYPERTENSION, 2016, 34 : E175 - E175
  • [23] Decreased splanchnic adiponectin release contributes to lower plasma adiponectin concentrations in type 2 diabetes mellitus
    Basu, R
    Pajvani, UB
    Rizza, RA
    Scherer, PE
    DIABETES, 2004, 53 : A80 - A80
  • [24] Effects of pioglitazone on body fat and fat distribution in patients with Type 2 diabetes mellitus
    Storey, AM
    Perry, CJ
    Petrie, JR
    Priest, M
    Lean, MEJ
    DIABETOLOGIA, 2002, 45 : A235 - A235
  • [25] Type 2 diabetes mellitus: distribution of genetic markers in Kazakh population
    Sikhayeva, Nurgul
    Talzhanov, Yerkebulan
    Iskakova, Aisha
    Dzharmukhanov, Jarkyn
    Nugmanova, Raushan
    Zholdybaeva, Elena
    Ramanculov, Erlan
    CLINICAL INTERVENTIONS IN AGING, 2018, 13 : 377 - 388
  • [26] Effect of Liraglutide on Cardiovascular Markers in Type 2 Diabetes Mellitus
    Ren, Wei
    Guo, Jianjin
    Liu, Jie
    Xi, Guangxia
    DIABETES, 2015, 64 : A339 - A339
  • [27] Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus
    Sharma, Pramod Kumar
    Bhansali, Anil
    Sialy, Ravinder
    Malhotra, Samir
    Pandhi, Promila
    CLINICAL ENDOCRINOLOGY, 2006, 65 (06) : 722 - 728
  • [28] Adiponectin Is Associated with Changes in Bone Markers during Glycemic Control in Type 2 Diabetes Mellitus
    Kanazawa, Ippei
    Yamaguchi, Toru
    Yamauchi, Mika
    Yamamoto, Masahiro
    Kurioka, Soichi
    Yano, Shozo
    Sugimoto, Toshitsugu
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (08): : 3031 - 3037
  • [29] Adiponectin and cardiovascular risk profile in patients with type 2 diabetes mellitus: parameters associated with adiponectin complex distribution
    Hamilton, Mark P.
    Gore, M. Odette
    Ayers, Colby R.
    Wu, Xinyu
    McGuire, Darren K.
    Scherer, Philipp E.
    DIABETES & VASCULAR DISEASE RESEARCH, 2011, 8 (03): : 190 - 194
  • [30] Association of Islet Amyloid Polypeptide and Inflammatory Markers in Type 2 Diabetes Mellitus
    Badade, Zunjarrao Ganpat
    Shinde, Yogita Mahendra
    Kaul, Shibban K.
    Rai, Sandeep
    Kadam, Sameer
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2021, 15 (06)
12345